共 50 条
- [31] Efficacy of antibody response following the vaccination of SARS-CoV-2 infected and noninfected healthcare workers by two-dose inactive vaccine against COVID-19JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (06) : 2431 - 2437Dundar, BagnuKarahangil, KadriyeElgormus, Cagri SerdarTopsakal, Hatice Nur Halipci
- [32] Functional immune responses against SARS-CoV-2 variants of concern after fourth COVID-19 vaccine dose or infection in patients with blood cancerCELL REPORTS MEDICINE, 2022, 3 (10)Fendler, AnnikaShepherd, Scott T. C.Au, LewisWu, MaryHarvey, RuthWilkinson, Katalin A.Schmitt, Andreas M.Tippu, ZaydShum, BenjaminFarag, SheimaRogiers, AljosjaCarlyle, EleanorEdmonds, KimDel Rosario, LyraLingard, KarlaMangwende, MaryHolt, LucyAhmod, HamidKorteweg, JustineFoley, TaraBarber, TajaEmslie-Henry, AndreaCaulfield-Lynch, NiamhByrne, FionaDeng, DaqiKjaer, SvendSong, Ok-RyulQueval, Christophe J.Kavanagh, CaitlinWall, Emma C.Carr, Edward J.Caidan, SimonGavrielides, MikeMacRae, James, IKelly, GavinPeat, KemaKelly, DeniseMurra, AidaKelly, KayleighO'Flaherty, MollyShea, Robyn L.Gardner, GailMurray, DarrenPopat, SanjayYousaf, NadiaJhanji, ShamanTatham, KateCunningham, DavidVan As, NicholasYoung, Kate
- [33] Humoral immune response against SARS-CoV-2 after adapted COVID-19 vaccine schedules in healthy adults: The IMCOVAS randomized clinical trialVACCINE, 2024, 42 (25)Steenackers, KatieHanning, NikitaBruckers, LiesbethDesombere, IsabelleMarchant, ArnaudArien, Kevin K.Georges, DaphneeSoentjens, PatrickD'Onofrio, ValentinoHites, MayaBerens-Riha, NicoleDe Coster, IlseVan Damme, Pierre
- [34] RISK FACTORS FOR BREAKTHROUGH COVID-19 IN 14,713 UK ADULTS AFTER PRIMARY AND BOOSTER DOSES OF SARS-COV-2 VACCINESTHORAX, 2022, 77 : A25 - A26Vivaldi, G.Jolliffe, D. A.Holt, H.Talaei, M.Tydeman, F.Shaheen, S. O.Martineau, A. R.
- [35] Effectiveness of an mRNA vaccine booster dose against SARS-CoV-2 infection and severe COVID-19 in persons aged ≥60 years and other high-risk groups during predominant circulation of the delta variant in Italy, 19 July to 12 December 2021EXPERT REVIEW OF VACCINES, 2022, 21 (07) : 975 - 982Fabiani, MassimoPuopolo, MariaFilia, AntoniettaSacco, ChiaraMateo-Urdiales, AlbertoAlegiani, Stefania SpilaDel Manso, MartinaD'Ancona, FortunatoVescio, FeniciaBressi, MarcoPetrone, DanieleSpuri, MatteoRota, Maria CristinaMassari, MarcoDa Cas, RobertoMorciano, CristinaStefanelli, PaolaBella, AntoninoTallon, MarcoProietti, ValeriaSiddu, AndreaBattilomo, SerenaPalamara, Anna TeresaPopoli, PatriziaBrusaferro, SilvioRezza, GiovanniRiccardo, FlaviaIppolito, Francesca MennitiPezzotti, Patrizio
- [36] Short-term Adverse Events After the Third Dose of the BNT162b2 mRNA COVID-19 Vaccine in Adults 60 Years or OlderJAMA NETWORK OPEN, 2022, 5 (04) : E227657Auster, OrenFinkel, UriahDagan, NoaBarda, NoamLaufer, AlonBalicer, Ran D.Ben-Shachar, Shay
- [37] Efficacy of parainfluenza virus 5 (PIV5)-vectored intranasal COVID-19 vaccine as a single dose primer and booster against SARS-CoV-2 variantsJOURNAL OF VIROLOGY, 2025,Beavis, Ashley C.Li, ZhuoBriggs, KelseyGingerich, Maria CristinaWrobel, Elizabeth R.Najera, MariaAn, DongOrr-Burks, NicholeMurray, JackelynPatil, PreetishHuang, JiachenMousa, JarrodHao, LinhuiHsiang, Tien-YingGale Jr, MichaelHarvey, Stephen B.Tompkins, S. MarkHogan, Robert JeffreyLafontaine, Eric R.Jin, HongHe, Biao
- [38] Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trialNATURE COMMUNICATIONS, 2024, 15 (01)Carpp, Lindsay N.Hyrien, OllivierFong, YouyiBenkeser, DavidRoels, SanneStieh, Daniel J.Van Dromme, IlseVan Roey, Griet A.Kenny, AviHuang, YingCarone, MarcoMcDermott, Adrian B.Houchens, Christopher R.Martins, KarenJayashankar, LakshmiCastellino, FloraAmoa-Awua, ObrimpongBasappa, ManjulaFlach, BrittaLin, Bob C.Moore, ChristopherNaisan, MursalNaqvi, MuhammedNarpala, SandeepO'Connell, SarahMueller, AllenSerebryannyy, LeoCastro, MikeWang, JenniferPetropoulos, Christos J.Luedtke, AlexLu, YiwenYu, ChenchenJuraska, MichalHejazi, Nima S.Wolfe, Daniel N.Sadoff, JeraldGray, Glenda E.Grinsztejn, BeatrizGoepfert, Paul A.Bekker, Linda-GailGaur, Aditya H.Veloso, Valdilea G.Randhawa, April K.Andrasik, Michele P.Hendriks, JennyTruyers, CarlaVandebosch, AnStruyf, FrankSchuitemaker, Hanneke
- [39] Relative effectiveness of a 2nd booster dose of COVID-19 mRNA vaccine up to four months post administration in individuals aged 80 years or more in Italy: A retrospective matched cohort studyVACCINE, 2023, 41 (01) : 76 - 84Fabiani, MassimoMateo-Urdiales, AlbertoSacco, ChiaraRota, Maria CristinaPetrone, DanieleBressi, MarcoDel Manso, MartinaSiddu, AndreaProietti, ValeriaBattilomo, SerenaMenniti-Ippolito, FrancescaPopoli, PatriziaBella, AntoninoRiccardo, FlaviaPalamara, Anna TeresaRezza, GiovanniBrusaferro, SilvioPezzotti, Patrizio
- [40] Young Age, Female Sex, and No Comorbidities Are Risk Factors for Adverse Reactions after the Third Dose of BNT162b2 COVID-19 Vaccine against SARS-CoV-2: A Prospective Cohort Study in JapanVACCINES, 2022, 10 (08)Urakawa, RyutaIsomura, Emiko TanakaMatsunaga, KazuhideKubota, Kazumi